{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:05:14Z","timestamp":1780553114915,"version":"3.54.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00219213"],"award-info":[{"award-number":["RS-2023-00219213"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The increasing prevalence of antibiotic-resistant pathogens highlights the urgent need for new strategies to overcome antimicrobial resistance. Adjuvant compounds that potentiate antibiotic activity represent a promising alternative to the development of new antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Through high-throughput screening of a chemical library, an aryloxyphenol compound, PA74, was identified as a polymyxin adjuvant candidate. Checkerboard analyses, serial passage assays, cytotoxicity assays, and functional analyses using FabI-overexpressing and point-mutant strains were performed. In vivo efficacy was evaluated using a murine skin infection model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PA74 potentiated polymyxin B against polymyxin-resistant Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli. Among six antibiotic classes tested, PA74 additionally enhanced the activity of tetracycline and chloramphenicol. Structurally, PA74 is a triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol) analogue in which the 2,4-dichlorophenol moiety is replaced by 4-amino-3-chlorophenol. PA74 exhibited a markedly lower propensity for resistance development over 15 days compared with triclosan. PA74 also showed minimal cytotoxicity across mammalian cell lines. Increased FabI abundance attenuated the synergistic effect of the polymyxin B\u2013PA74 combination, indicating that FabI contributes to PA74-mediated activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PA74 co-treatment significantly improved therapeutic outcomes in a murine skin infection model, establishing PA74 as a promising adjuvant candidate for polymyxin B against drug-resistant Gram-negative pathogens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1814325","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:43:23Z","timestamp":1780551803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An aryloxyphenol potentiates polymyxin against multidrug-resistant Acinetobacter baumannii"],"prefix":"10.3389","volume":"16","author":[{"given":"Kyungjin","family":"Lee","sequence":"first","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeseul","family":"Kim","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]},{"name":"Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST)","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yura","family":"Lee","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]},{"name":"Department of Biosystems and Bioengineering, Korea Research Institute of Bioscience and Biotechnology (KRIBB) School of Biotechnology, UST","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongseo","family":"Lee","sequence":"additional","affiliation":[{"name":"Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Division of Medicinal Chemistry and Pharmacology, KRICT School, UST","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaesung","family":"Kwak","sequence":"additional","affiliation":[{"name":"Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Division of Medicinal Chemistry and Pharmacology, KRICT School, UST","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Yeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Seob","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nano-Bioengineering, Incheon National University","place":["Incheon, Republic of Korea"]},{"name":"Institute for New Drug Development, College of Life Science and Bioengineering, Incheon National University","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choong-Min","family":"Ryu","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]},{"name":"Department of Biosystems and Bioengineering, Korea Research Institute of Bioscience and Biotechnology (KRIBB) School of Biotechnology, UST","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwi Won","family":"Seo","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]},{"name":"Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST)","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B2","unstructured":"Drug-resistant infections: A threat to our economic future\n          \n          \n          \n          2017"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.17.628820","article-title":"Assessing the efficacy of therapeutically promising combination of polymyxin B and triclosan against colistin-resistant Klebsiella pneumoniae","author":"Biswas","year":"2025","journal-title":"bioRxiv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1038\/s41467-024-49200-5","article-title":"Potent activity of polymyxin B is associated with long-lived super-stoichiometric accumulation mediated by weak-affinity binding to lipid A","volume":"15","author":"Buchholz","year":"2024","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","article-title":"Beta-lactams and beta-lactamase inhibitors: An overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00780","article-title":"The impact of triclosan on the spread of antibiotic resistance in the environment","volume":"5","author":"Carey","year":"2014","journal-title":"Front. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","article-title":"Multidrug efflux pumps: structure, function and regulation","volume":"16","author":"Du","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/pmc.s14459","article-title":"Antibiotics and bacterial resistance in the 21st century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspect. Medicin. Chem."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127408","article-title":"Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling","volume":"30","author":"Fujii","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1021\/es500495p","article-title":"On the need and speed of regulating triclosan and triclocarban in the United States","volume":"48","author":"Halden","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.micro.56.012302.160310","article-title":"Function of pseudomonas porins in uptake and efflux","volume":"56","author":"Hancock","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.1074\/jbc.274.16.11110","article-title":"Mechanism of triclosan inhibition of bacterial fatty acid synthesis","volume":"274","author":"Heath","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"30316","DOI":"10.1074\/jbc.273.46.30316","article-title":"Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis","volume":"273","author":"Heath","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B16","unstructured":"Tackling drug-resistant infections globally: Final report and recommendations\n          \n          \n            \n              J\n              O. N.\n            \n          \n          \n          2016"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7090344","article-title":"Characterization of mcr-1-harboring plasmids from pan drug-resistant Escherichia coli strains isolated from retail raw chicken in South Korea","volume":"7","author":"Kim","year":"2019","journal-title":"Microorganisms"},{"key":"B18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/jac\/dkac445","article-title":"Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii","volume":"78","author":"Kim","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/dnares\/dsi012","article-title":"Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research","volume":"12","author":"Kitagawa","year":"2005","journal-title":"DNA Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/s0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/cmr.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/28970","article-title":"Triclosan targets lipid synthesis","volume":"394","author":"Mcmurry","year":"1998","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrmicro3047","article-title":"Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis","volume":"11","author":"Needham","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1128\/jb.178.20.5853-5859.1996","article-title":"Multidrug efflux pumps of gram-negative bacteria","volume":"178","author":"Nikaido","year":"1996","journal-title":"J. Bacteriol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1128\/aac.01673-13","article-title":"Tools for characterizing bacterial protein synthesis inhibitors","volume":"57","author":"Orelle","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1469-0691.2004.00763.x","article-title":"Efflux-mediated multiresistance in gram-negative bacteria","volume":"10","author":"Poole","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"B27","article-title":"Bracing for superbugs: Strengthening environmental action in the One Health response to antimicrobial resistance","year":"2023"},{"key":"B28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/jac\/dkh171","article-title":"Whither triclosan","volume":"53","author":"Russell","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/cmr.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1021\/bi0300229","article-title":"Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs","volume":"42","author":"Sivaraman","year":"2003","journal-title":"Biochemistry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.31478\/201606d","article-title":"Antibiotic resistance in humans and animals","author":"Spellberg","year":"2016"},{"key":"B32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.bi.46.070177.003451","article-title":"Polymyxin and related peptide antibiotics","volume":"46","author":"Storm","year":"1977","journal-title":"Annu. Rev. Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/cmr.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1128\/mr.56.3.395-411.1992","article-title":"Agents that increase the permeability of the outer membrane","volume":"56","author":"Vaara","year":"1992","journal-title":"Microbiol. Rev."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24020249","article-title":"Polymyxin derivatives that sensitize gram-negative bacteria to other antibiotics","volume":"24","author":"Vaara","year":"2019","journal-title":"Molecules"},{"key":"B36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/aac.24.1.114","article-title":"Polycations as outer membrane-disorganizing agents","volume":"24","author":"Vaara","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure--activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.839808","article-title":"Antibiotic combination therapy: A strategy to overcome bacterial resistance to aminoglycoside antibiotics","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/10937404.2017.1399306","article-title":"Triclosan exposure, transformation, and human health effects","volume":"20","author":"Weatherly","year":"2017","journal-title":"J. Toxicol. Environ. Health B. Crit. Rev."},{"key":"B40","volume-title":"Antimicrobial resistance: global report on surveillance","year":"2014"},{"key":"B41","volume-title":"Antimicrobial resistance","year":"2024"},{"key":"B42","volume-title":"Antimicrobial resistance","year":"2025"},{"key":"B43","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tim.2016.07.008","article-title":"Antibiotic adjuvants: Rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-pharmtox-010715-103417","article-title":"Triclosan: A widespread environmental toxicant with many biological effects","volume":"56","author":"Yueh","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1814325\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:43:29Z","timestamp":1780551809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1814325\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2026.1814325"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1814325","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"article-number":"1814325"}}